Delivery Order SPE2DB22D3301-SPE2DB24FZ4JX

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $4,470.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET UU 30S. This delivery order was placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment...
The U.S. Defense Logistics Agency (DLA) awarded a $2,937.60 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide DESCOVY 200-25 MG TABLET medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows DLA Troop Support Medical to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals, to support military treatment programs and...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (SPE2DX15D3012|SPE2DX24F8KZ8) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of DESCOVY 200-25 MG TABLET medication. The $29,665.90 contract has a performance period through March 21, 2024 and does not utilize any set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) with a $999,999,999.00 ceiling...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET UU 30S. The contract has a ceiling value of $6,519.60 and a completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order worth $10,726.11 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of DESCOVY 200-25 mg tablets. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of DESCOVY 200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a ceiling value of $11,113.25 and a period of performance through April 15, 2024. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company, to provide DESCOVY 200-25MG 30S pharmaceuticals. The contract has a ceiling value of $35,925.70 and an ultimate completion date of August 10, 2022. This award is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which...
This is a $3,960.13 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of DESCOVY 200-25 MG TABLET, a prescription medication, with a performance period ending on July 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which provides a wide range of pharmaceutical and medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET in 30-count packages. The contract has a firm fixed price of $6,897.30 and a completion date of April 26, 2024. This order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a total potential value of up...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DESCOVY 200-25 MG TABLET. The contract has a firm fixed price of $12,948.90 and a period of performance ending on July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ4JX
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $3,956.17 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 MG TABLET, a pharmaceutical product. This order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and the ultimate completion date is September 12, 2024.

Generated 12/11/24, 9:32 AM